Marlborough, MA, United States of America

Ocata Therapeutics, Inc.


USPTO Granted Patents = 10


Forward Citations = 177

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Robert P Lanza (10 out of 59 patents)

silverMedal Irina V Klimanskaya (7 out of 25 patents)

bronzeMedal Erin Anne Kimbrel (2 out of 5 patents)

4.  Jianlin Chu (2 out of 4 patents)

5.  Nicholas Arthur Kouris (2 out of 4 patents)

6.  Shi-Jiang Lu (1 out of 23 patents)

7.  Roy Geoffrey Sargent (2 patents)

8.  Michael D West (46 patents)

9.  Karen B Chapman (33 patents)


10 patents:

Ocata Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of regenerative medicine products to treat degenerative eye diseases. Their innovative technology platform allows for the production of high-quality, sustainable cell-based therapeutics to address unmet medical needs in ophthalmology. With a strong track record of success in clinical trials, Ocata Therapeutics is poised to revolutionize the treatment of vision-related conditions.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

10 Patents

#45 in Marlborough, MA

#1,770 in Massachusetts

#29,828 in US

#55,954 in the World

Marlborough, MA (US)
Marlborough, MA, United States of America
Forward Citations = 177

9 inventors:

Please report any incorrect information to [email protected]
Loading…